Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 10 de 10
1.
NPJ Biofilms Microbiomes ; 10(1): 25, 2024 Mar 20.
Article En | MEDLINE | ID: mdl-38509085

Hyperuricemia (HUA) is a metabolic syndrome caused by abnormal purine metabolism. Although recent studies have noted a relationship between the gut microbiota and gout, whether the microbiota could ameliorate HUA-associated systemic purine metabolism remains unclear. In this study, we constructed a novel model of HUA in geese and investigated the mechanism by which Lactobacillus rhamnosus GG (LGG) could have beneficial effects on HUA. The administration of antibiotics and fecal microbiota transplantation (FMT) experiments were used in this HUA goose model. The effects of LGG and its metabolites on HUA were evaluated in vivo and in vitro. Heterogeneous expression and gene knockout of LGG revealed the mechanism of LGG. Multi-omics analysis revealed that the Lactobacillus genus is associated with changes in purine metabolism in HUA. This study showed that LGG and its metabolites could alleviate HUA through the gut-liver-kidney axis. Whole-genome analysis, heterogeneous expression, and gene knockout of LGG enzymes ABC-type multidrug transport system (ABCT), inosine-uridine nucleoside N-ribohydrolase (iunH), and xanthine permease (pbuX) demonstrated the function of nucleoside degradation in LGG. Multi-omics and a correlation analysis in HUA patients and this goose model revealed that a serum proline deficiency, as well as changes in Collinsella and Lactobacillus, may be associated with the occurrence of HUA. Our findings demonstrated the potential of a goose model of diet-induced HUA, and LGG and proline could be promising therapies for HUA.


Hyperuricemia , Lacticaseibacillus rhamnosus , Humans , Hyperuricemia/therapy , Nucleosides , Lactobacillus , Proline , Purines
2.
J Org Chem ; 88(21): 14911-14927, 2023 Nov 03.
Article En | MEDLINE | ID: mdl-37870904

The domino reaction of alkyl and aryl isocyanides with two molecules of 2-arylidene-1,3-indanediones in acetonitrile at 80 °C resulted in unique functionalized spiro[dibenzo[a,f]azulene-6,2'-indenes] in good yields, in which the two 2-arylidene-1,3-indanediones acted as different building blocks to construct the polycyclic system. More importantly, the unprecedented anticipation of the ortho-position of benzylidene group to form a novel dibenzo[a,f]azulene ring through a formal [5 + 2] cycloaddition process was first observed. On the other hand, DABCO-promoted reaction of the isocyanides with two molecules of 2-arylidene-1,3-indanediones in acetonitrile at 80 °C afforded functionalized spiro[cyclopenta[a]-indene-2,2'-indene] derivatives.

3.
Anim Biosci ; 34(3): 457-462, 2021 Mar.
Article En | MEDLINE | ID: mdl-32898960

OBJECTIVE: The aim of this study was to investigate the effects of Enteromorpha powder supplementation on reproduction-related hormones and genes in the late laying period of Zi geese. METHODS: A total of 312 (1-year-old) Zi geese with similar laying rate were randomly divided into 2 groups with 6 replicates each, each with 21 female geese and 5 male geese. The control group was fed with a basal diet and the test group was fed with a diet containing 3% Enteromorpha powder. The trial period lasted for 7 weeks. RESULTS: Our results showed that the laying rate was improved in the test group at each week of trial (p<0.01), and the levels of estradiol in serum and prolactin in ovary were increased compared with the control group (p<0.05). CONCLUSION: Based on above results, Enteromorpha powder supplementation at 3% could promote reproductive performance during the late laying period of Zi geese.

4.
Front Biosci (Landmark Ed) ; 22(8): 1365-1378, 2017 03 01.
Article En | MEDLINE | ID: mdl-28199208

The purpose of this study was to assess the anti-tumor effects of macrophage migration inhibitory factor (MIF) siRNA on colorectal cancer in a mouse xenograft model. MIF specific siRNA (MIF siRNA) or a nonspecific control siRNA was introduced to murine colorectal cancer CT-26 cells. Mouse xenograft models of colorectal cancer were established. MIF siRNA, control siRNA or water was injected twice a week intravenously for 4 weeks. MIF siRNA inhibited the proliferation and migration, while induced apoptosis of CT-26 cells in vitro. Injection of MIF siRNA resulted in a significant decrease of serum MIF and VEGF levels, and the weight and volume of cecum-grafted tumors in vivo. In contrast, the number of apoptotic cells and caspase-3 expression were increased by MIF siRNA in cecum graft tumor tissues. Moreover, the water and fodder consumption were significantly improved by MIF siRNA treatment. Importantly, MIF siRNA reduced the hepatic metastases from colorectal cancer. Our results suggest that siRNA targeting MIF is a promising agent for the treatment of hepatic metastasis of colorectal cancer cells.


Colorectal Neoplasms/pathology , Colorectal Neoplasms/therapy , Intramolecular Oxidoreductases/antagonists & inhibitors , Liver Neoplasms, Experimental/prevention & control , Liver Neoplasms, Experimental/secondary , Macrophage Migration-Inhibitory Factors/antagonists & inhibitors , Animals , Antigens, Differentiation, B-Lymphocyte/genetics , Antigens, Differentiation, B-Lymphocyte/metabolism , Apoptosis , Caspase 3/genetics , Caspase 3/metabolism , Caspase 8/genetics , Caspase 8/metabolism , Cell Line, Tumor , Colorectal Neoplasms/genetics , Down-Regulation , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class II/metabolism , Intramolecular Oxidoreductases/genetics , Intramolecular Oxidoreductases/metabolism , Liver Neoplasms, Experimental/genetics , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/metabolism , Male , Mice , Mice, Inbred BALB C , Neoplasm Invasiveness , RNA, Small Interfering/genetics , T-Lymphoma Invasion and Metastasis-inducing Protein 1/genetics , T-Lymphoma Invasion and Metastasis-inducing Protein 1/metabolism
5.
BMC Anesthesiol ; 15: 27, 2015.
Article En | MEDLINE | ID: mdl-25774090

BACKGROUND: To determine the median effective concentration of sufentanil as an analgesic during wake-up tests after sevoflurane anesthesia during surgery for adolescent idiopathic scoliosis (AIS). METHODS: This is a randomised controlled trial. Sixty patients aged 13-18 years scheduled for AIS surgery were randomized into six groups of 10 patients each to receive target effect-site concentrations of sufentanil of 0.19, 0.1809, 0.1723, 0.1641, 0.1563, and 0.1489 ng/ml (target concentration ratio, 1.05). Wake-up time was recorded. Median EC50 and 95% confidence interval (CI) for sufentanil target-controlled infusion (TCI) were determined using Kärber's method. The primary outcome was median EC50 for sufentanil TCI as an analgesic during the wake-up test after sevoflurane anesthesia during surgery for AIS. RESULTS: The EC50 and 95% CI of sufentanil TCI were 0.1682 ng/ml and 0.1641 ~ 0.1724 ng/ml, respectively. CONCLUSIONS: The EC50 of sufentanil TCI was 0.1682 ng/ml (95% CI: 0.1641 ~ 0.1724 ng/ml) during sevoflurane anesthesia in adolescents undergoing surgery for idiopathic scoliosis with intraoperative wake-up tests. TRIAL REGISTRATION: Clinicaltrials.gov identifier: ChiCTR-TTRCC-12002696.


Monitoring, Intraoperative , Sufentanil/administration & dosage , Sufentanil/pharmacology , Wakefulness/drug effects , Adolescent , Anesthetics, Inhalation/pharmacology , Anesthetics, Intravenous/adverse effects , Anesthetics, Intravenous/pharmacology , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Methyl Ethers/pharmacology , Scoliosis/surgery , Sevoflurane , Spinal Cord Injuries/chemically induced , Spinal Cord Injuries/prevention & control , Sufentanil/adverse effects , Time Factors
6.
Pain ; 155(4): 783-791, 2014 Apr.
Article En | MEDLINE | ID: mdl-24447511

Patients with bone cancer commonly experience bone pain that is severe, intolerable, and difficult to manage. The rostral ventromedial medulla (RVM) plays an important role in the development of chronic pain via descending facilitation of spinal nociception. The compelling evidence shows that glial P2X7 receptor (P2X7R) is involved in the induction and maintenance of chronic pain syndromes. The present study explored the mechanism of glial activation and P2X7R expression underlying the induction of bone cancer pain. The results demonstrated that microglia and astrocytes in the RVM were markedly activated in bone cancer rats, and the expression of P2X7R was significantly upregulated. Injection of Brilliant Blue G (BBG), an inhibitor of P2X7R, into the RVM significantly alleviated pain behaviors of cancer rats, which was supported by intra-RVM injection of RNA interference targeting the P2X7R in the RVM. It is suggested that activation of microglia-expressed P2X7R in the RVM contributes to bone cancer pain. Given that 5-HT in the RVM is involved in modulating spinal nociception, changes in 5-HT and Fos expression were addressed in the spinal cord. Inhibition of P2X7R by BBG or small-interference RNA targeting P2X7 in the RVM markedly reduced 5-HT level and Fos expression in the spinal cord. The data clearly suggest that the activation of microglial P2X7R in the RVM contributes to the development of bone cancer pain via upregulation of spinal 5HT levels by the descending pain facilitatory system.


Afferent Pathways/metabolism , Bone Neoplasms/complications , Medulla Oblongata/metabolism , Pain/etiology , Pain/pathology , Receptors, Purinergic P2X7/metabolism , Afferent Pathways/drug effects , Animals , CD11b Antigen/metabolism , Disease Models, Animal , Female , Gene Expression Regulation, Neoplastic/drug effects , Glial Fibrillary Acidic Protein/metabolism , Medulla Oblongata/drug effects , Morphine/therapeutic use , Narcotics/therapeutic use , Pain/drug therapy , Pain Measurement/drug effects , Pain Measurement/methods , Phosphopyruvate Hydratase/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Purinergic P2X7/genetics , Serotonin/metabolism
7.
Water Res ; 50: 90-100, 2014 Mar 01.
Article En | MEDLINE | ID: mdl-24361706

A molecular imprinted particle for Bisphenol A (BPA-MIP) was successfully used for selective recognition of BPA in the water. The contaminants such as 3, 3', 5, 5'-Tetrabromobisphenol A (TBBPA), phenol and phenol red (PSP) were selected as the latent interferon to investigate the selectivity. The binding efficiencies of BPA-MIP for different phenols were explored at various initial concentrations in the single and mixed water. Various selective parameters such as Kd, K and K' of BPA-MIP for BPA were calculated. The influences of humic acid (HA) and common ions on the BPA binding were investigated. A physical model was proposed to illustrate the selective binding performance. The results showed that BPA-MIP possessed strong selectivity for BPA in competitive water, while the other similar phenols had the influence for BPA binding at the order of TBBPA > phenol > PSP. The HA and common ions indicated little effect on the BPA binding process onto BPA-MIP. It was found that the molecular geometry and the hydrogen bonding interactions between the hydroxyl and carboxyl played an important role in recognizing the target molecular in the binding process.


Benzhydryl Compounds/chemistry , Molecular Imprinting , Phenols/chemistry , Water Pollutants, Chemical/chemistry , Water/chemistry , Humic Substances/analysis , Ions , Kinetics , Models, Molecular , Phenolsulfonphthalein/chemistry , Polybrominated Biphenyls/chemistry , Temperature
8.
J Clin Anesth ; 25(4): 263-7, 2013 Jun.
Article En | MEDLINE | ID: mdl-23659825

STUDY OBJECTIVE: To investigate the effect of the intraoperative wake-up test on sevoflurane-sufentanil anesthesia for adolescent idiopathic scoliosis (AIS) surgery. DESIGN: Randomized, double-blind, parallel trial. SETTING: Operating room. PATIENTS: 30 ASA physical status 1 patients, aged 13 to 20 years, scheduled for AIS surgery. INTERVENTIONS: Patients were randomized to two groups: Group W patients received sevoflurane-sufentanil combined anesthesia and underwent the intraoperative wake-up test; Group NW received sevoflurane-sufentanil combined anesthesia without the wake-up test. Anesthesia was induced with an intravenous (IV) injection of midazolam, propofol, and sufentanil and maintained with sevoflurane inhalation, a target-controlled infusion (TCI) of sufentanil, and IV infusion of cisatracurium besylate. MEASUREMENTS: The primary outcome was postoperative delirium. Secondary outcomes were duration of surgery, duration of anesthesia, intraoperative blood loss and transfusion, exposure of drugs administered, time to eye opening, extubation, and consciousness. MAIN RESULTS: Postoperative delirium occurred in one patient from each group (P > 0.05). There were no significant differences between the two groups in duration of surgery (322 ± 65 min vs 336 ± 72 min), duration of anesthesia (356 ± 76 min vs 368 ± 81 min), intraoperative blood loss (1847 ± 423 mL vs 1901 ± 451 mL) and transfusion (1663 ± 398 mL vs 1649 ± 382 mL), average exposure of drugs (72 ± 13 mg vs 75 ± 15 mg for propofol, 116 ± 28 µg vs 109 ± 25 µg for sufentanil, and 22 ± 5 vs 23 ± 4 mg for cisatracurium), time to eye opening (4.7 ± 1.5 min vs 4.8 ± 1.4 min), extubation (7.5 ± 2.0 min vs 7.3 ± 2.2 min), and consciousness (8.9 ± 1.8 min vs 9.1 ± 2.1 min) (all P > 0.05). CONCLUSIONS: Sevoflurane-sufentanil combined anesthesia provides hemodynamic stability and rapid recovery from AIS surgery. There is no correlation between the intraoperative wake-up test and postoperative delirium after sevoflurane-sufentanil combined anesthesia.


Anesthetics, Inhalation/administration & dosage , Methyl Ethers/administration & dosage , Scoliosis/surgery , Sufentanil/administration & dosage , Adolescent , Airway Extubation , Anesthesia Recovery Period , Anesthetics, Intravenous/administration & dosage , Atracurium/administration & dosage , Atracurium/analogs & derivatives , Delirium/epidemiology , Double-Blind Method , Female , Humans , Male , Monitoring, Intraoperative/methods , Operative Time , Postoperative Complications/epidemiology , Propofol/administration & dosage , Sevoflurane , Time Factors , Wakefulness , Young Adult
9.
Zhonghua Wai Ke Za Zhi ; 51(2): 123-6, 2013 Feb 01.
Article Zh | MEDLINE | ID: mdl-23711004

OBJECTIVE: To evaluate the safety, effectiveness, and outcomes of holmium laser enucleation of the prostate (HoLEP) for patients with symptomatic enlarged prostate after 11 years of experience. METHODS: The 3162 evaluable patients treated with holmium laser enucleation of the prostate at our institution between August 2001 and August 2011 were retrospectively analyzed. Study variables included International Prostate Symptom Score, quality of life, maximum urinary flow rate, and incidence of complications. RESULTS: HoLEP were performed successfully completed, not patients which occurs as electric cutting syndrome. The operation time was (60.8 ± 18.4) minutes; average resection of prostate quality was (45.4 ± 24.4) g. The hemoglobin reduce though surgery was (1.81 ± 0.93) g/L; percentage of red blood cell change was 1.24% ± 0.43%, and sodium blood drop was (1.14 ± 0.35) mmol/L. Postoperative patients of hospital stay (3.1 ± 1.1) days, average time of indwelling catheter time was (2.3 ± 0.8) days. Patients were followed up for 6-131 months time, an average of 32.4 months. Postoperative patients with international prostate symptom score progressive declined. The quality of life score was 2.2 ± 1.7, and it less than preoperative (5.7 ± 3.3, t = 2.447, P < 0.01). The time of follow-up droped further, and postoperative comparative differences have statistical significance (t = 2.179, 2.228, 2.306 and 2.365, P < 0.05). The maximum urinary flow rate also improved (P < 0.05). Postoperative complications included bladder neck contracture (4 cases), urinary tract infection (107 cases), urethral stricture (11 cases) and urinary incontinence (11 cases). The 11 patients reoperation. CONCLUSIONS: HoLEP treatment of benign prostatic hyperplasia could achieve the advantages of open surgery the same effect. It had fewer damage, faster recovery, fewer complications, and is a good treatment option.


Lasers, Solid-State , Prostatic Hyperplasia/surgery , Transurethral Resection of Prostate , Adult , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
10.
Injury ; 42(4): 356-61, 2011 Apr.
Article En | MEDLINE | ID: mdl-20863491

INTRODUCTION: The spoke injuries of the lower extremity seems never stop haunting the surgeons since its first report 62 years ago. A prospective study of motorcycle spoke injuries in the heel was undertaken to study the injury mechanism, the treatment protocols, and the outcomes. PATIENTS AND METHODS: From 2001 to 2010, 89 cases of motorcycle spoke injuries of the heel were examined. The various injury mechanisms were analysed. Flaps and other reconstruction surgeries were used to manage the involved extremity. RESULTS: The mechanisms of the motorcycle spoke injuries of the heel had some unique features. A grading system was developed for the injuries according to the tissues involved. The surgery protocols primarily consisted of flap transfers, Achilles tendon reconstruction, and calcaneus management. CONCLUSIONS: The eradication of the motorcycle spoke injuries is a difficult task, but the treatment outcomes have been greatly improved due to the advancement of surgical techniques.


Accidents, Traffic/statistics & numerical data , Achilles Tendon/injuries , Calcaneus/injuries , Heel/injuries , Motorcycles , Soft Tissue Injuries/surgery , Achilles Tendon/surgery , Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Prospective Studies , Plastic Surgery Procedures/methods , Risk Factors , Soft Tissue Injuries/etiology , Surgical Flaps , Trauma Severity Indices , Wound Healing/physiology , Young Adult
...